NCTD has been shown to inhibit the expression of Ki-67 and Bcl-2, induce S-phase cell-cycle arrest, and directly or indirectly downregulate the VEGF-A,-C,-D/VEGFR-2,-3 signaling pathways, thereby inhibiting the proliferation of CRC cells [32]. This evidence concerns the gene BCL2 and colorectal carcinoma.